David Ross Parkinson

Director, ABBOTT BIOTHERAPEUTICS CORP.

Companies

Essa Pharma (United States)President Oct 15, 2025 to now¹
Essa Pharma (United States)Board member Oct 1, 2020 to now²
Essa Pharma (United States)Chief executive officer Oct 1, 2020 to now²
CTI BioPharmaBoard member Jun 7, 2017 to Jun 26, 2023³
Forte Biosciences, Inc.Board member Apr 12, 2017 to Oct 4, 2019⁴
Dare Bioscience, Inc.Board member Oct 31, 2014 to Jan 5, 2017⁵
Molecular Templates, Inc.Board member Jun 1, 2010 to Jun 28, 2016⁶
Ambit BiosciencesBoard member May 15, 2013 to Nov 13, 2014⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Essa Pharma (United States)0 shares⁸Oct 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 9, 2025Returned to company 65,675 shares of Essa Pharma (United States)⁸
Dec 14, 2023Bought 9,223 shares at $2.30 of Essa Pharma (United States)⁹
Dec 30, 2022Bought 3,067 shares at $2.60 of Essa Pharma (United States)¹⁰
Dec 22, 2022Bought 21,367 shares at $2.39 of Essa Pharma (United States)¹⁰
Jun 30, 2022Bought 4,887 shares at $2.96 of Essa Pharma (United States)¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREssa Pharma (United States), President
2
SEC EDGAREssa Pharma (United States), Board member
3
SEC EDGARCTI BioPharma, Board member
4
SEC EDGARForte Biosciences, Inc., Board member
5
SEC EDGARDare Bioscience, Inc., Board member
6
SEC EDGARMolecular Templates, Inc., Board member
7
SEC EDGARAmbit Biosciences, Board member
8
SEC EDGAREssa Pharma (United States) shares after the filing of Oct 9, 2025
9
SEC EDGARForm 4 filed Dec 18, 2023
10
SEC EDGARForm 4 filed Jan 5, 2023
11
SEC EDGARForm 4 filed Jul 5, 2022